Nuparp 300mg Tablet

28,499.00

43% Off
Close
Price Summary
  • 49,800.00
  • 28,499.00
  • 43%
  • 28,499.00
  • Overall you save 21,301.00 (43%) on this product
In Stock
Highlights:

Buy Nuparp 300mg Tablet HivHub

Compare
Description

Last Updated on May 20, 2024 by admin

Buy Nuparp 300mg Tablet Only @28499

Nuparp 300mg Tablet INTRODUCTION

SALT COMPOSITION: Rucaparib 300mg Tablet

What is Nuparp 300mg Tablet and How Does it Work?

Nuparp 300mg Tablet is a targeted therapy primarily utilized in the treatment of specific types of cancer, most notably ovarian, fallopian tube, and peritoneal cancers. Developed through rigorous scientific research, Nuparp 300mg Tablet received approval from regulatory authorities such as the U.S. Food and Drug Administration (FDA) due to its demonstrated efficacy and safety in clinical trials. As a PARP (poly ADP-ribose polymerase) inhibitor, Nuparp 300mg Tablet plays a crucial role in the management and treatment of cancers that are characterized by BRCA1 or BRCA2 gene mutations.

The mechanism of action of Nuparp 300mg Tablet centers on its ability to inhibit the PARP enzyme. PARP is essential for the repair of single-strand breaks in DNA. When PARP activity is blocked by Nuparp 300mg Tablet, these single-strand breaks accumulate and eventually lead to double-strand breaks, which are more challenging for cancer cells to repair, especially those already compromised by BRCA mutations. This accumulation of DNA damage ultimately leads to the death of cancer cells, while sparing normal cells that possess functional DNA repair mechanisms.

The clinical application of Nuparp 300mg Tablet extends to patients with advanced stages of ovarian, fallopian tube, and peritoneal cancers, particularly those who have undergone multiple lines of chemotherapy. By targeting and inhibiting PARP, Nuparp 300mg Tablet can significantly delay disease progression and improve overall survival rates. Its use is often considered when other treatment options have been exhausted or are deemed less effective.

In the broader landscape of cancer treatment, Nuparp 300mg Tablet represents a significant advancement in precision medicine. Unlike traditional chemotherapy, which can affect both healthy and cancerous cells, Nuparp 300mg Tablet targeted approach allows for more personalized treatment strategies. This precision not only enhances the efficacy of the treatment but also minimizes the adverse side effects commonly associated with conventional cancer therapies.

Uses of Nuparp 300mg Tablet

Benefits, Side Effects, and Considerations for Nuparp 300mg Tablet Use

Nuparp 300mg Tablet  tablets offer significant benefits, particularly for patients with certain types of cancer. One of the most notable advantages of using Nuparp 300mg Tablet is its efficacy in prolonging progression-free survival (PFS) in individuals with ovarian, fallopian tube, and peritoneal cancers. Clinical studies have demonstrated that Nuparp 300mg Tablet can effectively delay disease progression, thereby extending the period during which a patient remains free of cancer advancement. This extension of PFS can substantially improve the overall quality of life for patients, allowing them more time with fewer symptoms and better daily functioning.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Common

  • Rash
  • Constipation
  • Decrease in appetite
  • Diarrhea, indigestion
  • Nausea, vomiting
  • Changes in the blood count
  • Shortness of breath
  • Tiredness

Serious 

  • Severe anemia
  • Hypersensitivity reactions
  • Sepsis (blood infection)
  • Pneumonia

However, like all medications, Nuparp 300mg Tablet comes with potential side effects. Common adverse reactions include nausea, fatigue, and vomiting, which can be managed with supportive care and adjustments in lifestyle. More severe but less frequent side effects may include bone marrow suppression, leading to decreased blood cell counts, and elevations in liver enzymes, signaling potential liver function impairment. These serious side effects necessitate regular monitoring through blood tests and liver function assessments to ensure early detection and management of any complications.

Before starting Nuparp 300mg Tablet, patients should have an open discussion with their healthcare providers. Important topics to cover include any pre-existing health conditions, as these may influence the medication’s effectiveness or safety. Additionally, patients should inform their doctors about all other medications they are currently taking to avoid harmful drug interactions. Special precautions might also be necessary for patients with specific health issues, such as renal impairment or a history of liver disease. Adhering strictly to the prescribed dosage is crucial, as deviations can either diminish the drug’s efficacy or increase the risk of adverse reactions.

Overall, while Nuparp 300mg Tablet presents promising benefits for cancer patients by extending progression-free survival and enhancing quality of life, its use requires careful consideration of potential side effects and thorough communication with healthcare providers to ensure safe and effective treatment.

More Information about Nuparp 300mg Tablet

  • Store at 20°C to 25°C
  • Protect the medicine from light and excessive moisture.
  • Keep the medicine out of reach of children and pets
  • If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

References:

  1. Rubraca 250mg film-coated tablets – Summary of Product Characteristics (SmPC) – (emc). www.medicines.org.uk. [revised on 2022] [cited 2023 Apr 11]. Available from: https://www.medicines.org.uk/emc/product/10027/smpc
  2. HIGHLIGHTS OF PRESCRIBING INFORMATION – Rucaparib. [revised on 2018] [cited 2023 Apr 11]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209115s003lbl.pdf
  3. Shirley M. Rucaparib: A Review in Ovarian Cancer. Targeted Oncology. [2019 Apr 1] [cited 2022 Oct 15];14(2):237–46. Available from: https://pubmed.ncbi.nlm.nih.gov/30830551/
Scroll To Top
Close
Close
Close

My Cart

Shopping cart is empty!

Continue Shopping

Open chat
Need Help?
Welcome to HIVHUB
Hello
Can we help you ?